Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global BRIC Diabetes Care Devices Market, Product Type
7.1. BRIC Diabetes Care Devices Market, Product Type, 2020-2028
7.1.1. Blood Glucose Monitoring Devices
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Continuous Glucose Monitoring Devices
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Insulin Delivery Devices
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global BRIC Diabetes Care Devices Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, Product Type (2016-2028)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, Product Type (2016-2028)
8.2. Europe
8.2.1. Market Revenue and Forecast, Product Type (2016-2028)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, Product Type (2016-2028)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, Product Type (2016-2028)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, Product Type (2016-2028)
8.3. APAC
8.3.1. Market Revenue and Forecast, Product Type (2016-2028)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, Product Type (2016-2028)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, Product Type (2016-2028)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, Product Type (2016-2028)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, Product Type (2016-2028)
8.4. MEA
8.4.1. Market Revenue and Forecast, Product Type (2016-2028)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, Product Type (2016-2028)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, Product Type (2016-2028)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, Product Type (2016-2028)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, Product Type (2016-2028)
8.5. Latin America
8.5.1. Market Revenue and Forecast, Product Type (2016-2028)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, Product Type (2016-2028)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, Product Type (2016-2028)
Chapter 9. Company Profiles
9.1. Ypsomed AG
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Bayer AG
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. F. Hoffmann-La Roche Ltd
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Abbott Laboratories
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Becton, Dickinson, and Company
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Medtronic Plc
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Ypsomed AG
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Sanofi
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Novo Nordisk A/S
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. Arkray, Inc.
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Acon Laboratories, Inc.
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Terumo Corporation
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives
9.13. Dexcom, Inc.
9.13.1. Company Overview
9.13.2. Product Offerings
9.13.3. Financial Performance
9.13.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
Glossary of Terms